Floatz logo

111 assets in Rectal Carcinoma

Therapeutic assets addressing Rectal Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
L-Tryptophan, 1-(2-(Fluoro-18F)Ethyl)-
Rectal Carcinoma
Barbara Ann Karmanos Cancer InstituteP1C (39)
Mesenchymal Stem Cells Derived Exosomes
Rectal Carcinoma
Tehran University of Medical SciencesP1C (39)
Ucmym802
Rectal Carcinoma
UTC Therapeutics Inc.P1C (39)
Miyairi 588
Rectal Carcinoma
Huashan HospitalEarly P1C (36)
Clostridium Butyricum
Rectal Carcinoma
Huashan HospitalN/AD (30)
Dota-Fapi-04 Gallium Ga-68
Rectal Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyN/AD (30)
Fludeoxyglucose
Rectal Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyN/AD (30)
Somatostatin
Rectal Carcinoma
Tongji HospitalN/AD (30)
Krc-01
Rectal Carcinoma
Gustave Roussy, Cancer Campus, Grand ParisP2NR ()
QL706
Rectal Carcinoma
Changhai HospitalEarly P1NR ()
Showing 101 to 111 of 111 assets
PreviousPage 3 of 3Next